This phase II trial studies how well an exercise program and continuous Fitbit monitoring work for managing metabolic syndrome and cardiovascular disease risk …

Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05054296

Phase 2

Quantifying Optimal Relugolix Duration With Radiation in High Risk Prostate Cancer (QURE-PC)

This phase II trial evaluates the best duration for relugolix to be given in combination with radiation therapy when treating patients with high risk prostate …

Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8

~Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT06129851

← PreviousPage 2 of 2Next →